SPHK1 Is a Novel Target of Metformin in Ovarian Cancer

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-18-0409
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Metformin Intake Is Associated With Better Survival in Ovarian Cancer

Cancer
Cancer ResearchOncology
2012English

CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target

Frontiers in Oncology
Cancer ResearchOncology
2019English

TM4SF1 Is a Potential Target for Anti-Invasion and Metastasis in Ovarian Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Pyruvate Kinase M2 Is a Poor Prognostic Marker of and a Therapeutic Target in Ovarian Cancer

PLoS ONE
Multidisciplinary
2017English

Pyridoxine 5′-Phosphate Oxidase Is a Novel Therapeutic Target and Regulated by the TGF-β Signalling Pathway in Epithelial Ovarian Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2017English

STAT3 Signaling in Ovarian Cancer: A Potential Therapeutic Target

Journal of Cancer
Oncology
2020English

Identification of SPHK1 as a Therapeutic Target and Marker of Poor Prognosis in Cholangiocarcinoma

Oncotarget
Oncology
2015English

MYB: A Novel Player in Pathobiology of Ovarian Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

DDX49 Is a Novel Biomarker and Therapeutic Target for Lung Cancer Metastases

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy